Bleomycin and malignant neoplasm progression 
Bleomycin and malignant neoplasm progression Patient Reports February 11, 2012
Bleomycin Side Effects Report #4607061-5
Bleomycin side effect was reported by a Health Professional from on Mar 02, 2005. Male patient, 43 years of age, was diagnosed with testis cancer, metastatic renal cell carcinoma, back pain
and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: acute respiratory distress syndrome, arrhythmia supraventricular, malignant neoplasm progression. Bleomycin dosage: unknown. During the same period patient was treated with INTRON A, PROLEUKIN, ACETAMINOPHEN, DARVOCET, DURAGESIC. Patient was hospitalized. Patient died on 02/25/1998.Bleomycin Side Effects Report #5326807-4
Bleomycin side effect was reported by a Health Professional from JAPAN on May 14, 2007. Male patient, 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism
. Bleomycin dosage: unknown. During the same period patient was treated with PARAPLATIN, VEPESID, RANDA, KYTRIL, MEYLON, DIAMOX, DIPRIVAN. Patient died on 06/01/2006.Bleomycin Side Effects Report #5334390-2
Bleomycin side effect was reported by a Health Professional from JAPAN on May 24, 2007. Male patient, 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism
. Bleomycin dosage: unknown. During the same period patient was treated with PARAPLATIN, VEPESID, RANDA, KYTRIL, MEYLON, DIAMOX, DIPRIVAN. Patient died on 06/01/2006.Bleomycin Side Effects Report #5337075-1
Bleomycin side effect was reported by a Health Professional from JAPAN on May 25, 2007. Male patient, 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism
. Bleomycin dosage: unknown. During the same period patient was treated with PARAPLATIN, VEPESID, RANDA, KYTRIL, MEYLON, DIAMOX, DIPRIVAN. Patient died on 06/01/2006.Bleomycin Side Effects Report #5382633-1
Bleomycin side effect was reported by a Health Professional from JAPAN on July 09, 2007. Male patient, 29 years of age, was diagnosed with malignant mediastinal neoplasm and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: disseminated intravascular coagulation, interstitial lung disease, malignant neoplasm progression, pulmonary embolism
. Bleomycin dosage: unknown. During the same period patient was treated with PARAPLATIN, VEPESID, RANDA, KYTRIL, MEYLON, DIAMOX, DIPRIVAN. Patient died on 06/01/2006.Bleomycin Side Effects Report #5413270-8
Bleomycin side effect was reported by a Physician from ARGENTINA on July 30, 2007. Male patient, 40 years of age, was diagnosed with hodgkin's disease stage iv and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: bone marrow tumour cell infiltration, febrile neutropenia, hodgkin's disease mixed cellularity recurrent, hodgkin's disease mixed cellularity stage iv, leukoencephalopathy, malignant neoplasm progression, metastasis. Bleomycin dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE, CISPLATIN, CYTARABINE, ADRIAMYCIN PFS, CYCLOPHOSPHAMIDE, PROCARBAZINE HYDROCHLORIDE. Patient was hospitalized. Patient recovered.
Bleomycin Side Effects Report #5961759-5
Bleomycin side effect was reported by a Consumer or non-health professional from JAPAN on Nov 17, 2008. Female patient, 45 years of age, was diagnosed with diffuse large b-cell lymphoma and was treated with Bleomycin. After drug was administered, patient experienced the following side effects: ileus paralytic, malignant neoplasm progression. Bleomycin dosage: unknown. During the same period patient was treated with ETOPOSIDE, VINCRISTINE SULPHATE, CYCLOPHOSPHAMIDE, DOXORUBICIN, PREDNISONE. Patient died.